NMS-859

Research use only, not for human use.

NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.

NMS-859 is an effective and covalent inhibitor of valosin-containing protein (VCP)/p97 with IC50s of 0.37 μM and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.(In Vitro):NMS-859 suppresses the cell proliferation with IC50s of 3.0 μM and 3.5 μM in HeLa and HCT116 cell lines, respectively. NMS-859 shows weak inhibitory activity against VCPC522T.

NMS-859 is a potent VCP inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively. NMS-859 shows very weak inhibitory activity against VCPC522T. NMS-859 also suppresses the proliferation of cells, with IC50s of 3.5 μM and 3.0 μM in HCT116 and HeLa cell lines, respectively.

——

ZINC169324353

Others

Other Targets

ADC Cytotoxin| Microtubule/Tubulin

——

——

1449236-96-7

349.79

C15H12ClN3O3S

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (142.94 mM)

ClCC(=O)Nc1cccc(NC2=NS(=O)(=O)c3ccccc23)c1

——

(-20℃)

With Ice Pack

≥ 2 years